stimOS

stimOS GmbH operates as a specialized medtech company, focusing on advanced implant surface technologies designed to improve patient outcomes. Founded in 2016 by a team including three scientists from the University of Konstanz and a manager from the medical technology sector, the firm is led by CEO Dietmar Schaffarczyk.

The company's core business involves developing, refining, and marketing proprietary biochemical surface functionalization technologies for medical implant manufacturers. This business-to-business model is supplemented by acting as a legal manufacturer for its own line of implant systems. The revenue streams are diversified through providing surface treatment as a service, licensing its technologies to industrial partners, and selling its own branded products, such as the spineFuse implant system. Its client base consists of small to large enterprises in the orthopedic, spinal, and dental implant markets.

The flagship offering is the patented Mimicking Bone Technology (MBT), a biochemical procedure that creates a bone-identical interface on implant surfaces. This technology is engineered to trick the patient's body into recognizing the implant as natural bone, thereby initiating healthy bone formation, reducing inflammatory responses, and preventing implant loosening—a significant cause of revision surgeries. The process aims to provide superior implant anchorage, particularly in patients with compromised bone quality, such as those with osteoporosis.

Beyond MBT, stimOS has developed a portfolio of surface treatments including CITO for anti-bacterial properties, CEMENT for self-cementing capabilities, and PORTER for targeted drug delivery. The company also provides comprehensive support services to its partners, including regulatory assistance to meet international standards like the Medical Device Regulation (MDR), and services for qualifying 3D-printed patient-specific medical devices.

Keywords: medical implant technology, bone regeneration, implant surface functionalization, osteointegration, Mimicking Bone Technology, biochemical implant coating, orthopedic implants, dental implants, spinal fusion surgery, medtech, Dietmar Schaffarczyk, smart implants, anti-inflammatory implants, patient-specific devices, 3D printed implants, medical device regulation, drug delivery implants, bioactivation, osseointegration, biomimetic surfaces, PEEK implants